
If you take Flomax (tamsulosin) or a similar medication for prostate or urinary symptoms, your cataract surgeon needs to know before the day of surgery. A medication class called alpha-1 blockers changes how the iris behaves inside the eye, producing a pattern surgeons call intraoperative floppy iris syndrome, or IFIS. It is common, it is manageable, and it is one of the most important pieces of information you can bring to your cataract consult. This article explains what IFIS is, why it matters, and how a prepared surgeon operates differently when it is expected.
Intraoperative floppy iris syndrome was first described by Chang and Campbell in the Journal of Cataract and Refractive Surgery in 2005. They defined three intraoperative findings that together make up the syndrome:
These findings are not a complication in the traditional sense. They are a pattern of iris behavior that makes cataract surgery more technically challenging. When the surgeon knows it is coming, the case is planned around it. When the surgeon does not know, the risk of complications such as posterior capsule rupture, iris trauma, and incomplete cataract removal goes up (AAO EyeNet).
Tamsulosin (Flomax) is the drug most strongly associated with IFIS. It is an alpha-1 adrenergic receptor antagonist, and its selectivity for the alpha-1A receptor is the reason it works well for symptoms of benign prostatic hyperplasia. The iris dilator muscle is rich in alpha-1A receptors, and that is why the same medication that relaxes the smooth muscle of the prostate also affects the iris.
In the original Chang and Campbell series, IFIS occurred in approximately 86% of eyes in patients with a history of tamsulosin, compared with about 15% of eyes in patients taking alfuzosin, a less selective alpha-1 blocker. Subsequent studies have consistently confirmed tamsulosin as the highest-risk agent, though risk is not zero with any of the following:
A 2021 review in the peer-reviewed literature confirmed the association of tamsulosin use within 14 days of cataract surgery with an approximately 2.3-fold increase in serious postoperative complications compared with non-users (PMC8270016). This is not an argument to stop the medication; it is an argument to disclose it.
A standard cataract operation takes advantage of a well-dilated pupil. Eye drops given before surgery (phenylephrine, tropicamide, and occasionally atropine) open the pupil to 7 to 8 millimeters, giving the surgeon clear access to the cataract behind the iris. A stiff, well-dilated iris sits quietly during the case.
In an IFIS eye, three things can happen as soon as instruments enter the anterior chamber:
None of these is catastrophic in a prepared case. Each becomes a real problem when the surgeon is surprised mid-procedure.
When IFIS is expected, a cataract surgeon adjusts the case in three places: before surgery, at the start of surgery, and during the lens removal itself.
Several medications reduce the intraoperative behavior of the iris when given before or at the start of the case:
When medical dilation is not sufficient, a mechanical device holds the pupil open:
A prepared surgeon also adjusts the fluid dynamics and viscoelastic choices of the operation:
Each of these adjustments is a small thing on its own. Together, they convert a potentially difficult case into a predictable one.
This is the question patients ask most often, and the short answer is: do not change your medication without involving the prescriber who put you on it.
Stopping tamsulosin shortly before surgery does not reliably prevent IFIS. The medication's effect on alpha-1A receptors in the iris dilator muscle can persist for months to years after discontinuation, and IFIS has been reported in patients who took tamsulosin briefly and stopped years earlier. That is why every cataract surgeon asks about past as well as current tamsulosin use.
The right path when you are taking tamsulosin and need cataract surgery is coordination. Your urologist (or whichever prescriber started the medication) is managing your urinary symptoms or hypertension, and they may have a reason to keep you on the medication, switch you to an alternative, or temporarily pause it depending on your specific situation. Your ophthalmologist is planning your cataract surgery and will prepare the case for IFIS whether or not the medication has been adjusted. The two conversations are connected but separate, and you should have both.
Do not stop on your own. Tell each clinician about the other.
The data on cataract surgery in IFIS-risk patients is reassuring when surgery is planned. Large published series in the last decade document that, with preoperative atropine, intracameral mydriatics, and a pupil expansion device when needed, the rate of serious intraoperative complications drops toward the rate seen in non-IFIS cases. The 2.3-fold complication risk documented in the Canadian cohort discussed above applies specifically to patients where the IFIS risk was not managed proactively (PMC8270016).
In other words, the problem is not IFIS. The problem is an unprepared case. A subspecialty cataract surgeon who sees IFIS several times a week operates on IFIS-risk patients routinely and to the same visual outcome as other cataract patients.
Bring a complete medication list. Include:
We also recommend asking these three questions at your consult:
A clear answer to each means your surgeon's practice is mature on this question.
You can almost certainly proceed with cataract surgery if:
We would want to talk more if:
This is not a reason to avoid cataract surgery. It is a reason to choose a surgeon and a practice that handle IFIS routinely.
Intraoperative floppy iris syndrome, or IFIS, is a pattern of iris behavior during cataract surgery first described by Chang and Campbell in 2005. It has three features: a floppy, billowing iris that moves with fluid currents, a tendency of the iris to prolapse toward the surgical incisions, and progressive constriction of the pupil during the case.
Tamsulosin is the strongest known association. In the original Chang and Campbell study, IFIS occurred in approximately 86% of eyes in patients with a history of tamsulosin, compared to about 15% for alfuzosin. The effect can persist after the medication is stopped, so even a prior history is important to disclose.
Do not stop or adjust tamsulosin without discussing it with the prescriber who put you on it, usually your urologist. The receptor effect on the iris dilator muscle can persist even after discontinuation, so stopping does not reliably eliminate IFIS. Tell your cataract surgeon that you take or have taken tamsulosin, and let your surgeon and prescriber coordinate.
Yes. Experienced cataract surgeons operate on IFIS-at-risk patients routinely. With preoperative planning and the right intraoperative tools, including pupil expansion devices such as the Malyugin ring and intracameral medications, surgery proceeds safely. Outcomes in prepared IFIS cases are close to those in non-IFIS cases.
IFIS has been reported with other alpha-1 blockers used for urinary symptoms, including alfuzosin, silodosin, doxazosin, and terazosin. Saw palmetto, a supplement used for prostate symptoms, has also been associated with milder IFIS. Always disclose every medication and supplement at your cataract evaluation.
The Malyugin ring is a small, flexible square-shaped device inserted through a cataract incision to hold the pupil open during surgery. It mechanically stabilizes the iris and keeps the pupil from constricting during phacoemulsification, which is the single most useful tool for managing IFIS.
Bring a complete list of your current and past medications, including prostate medications and supplements. Specifically disclose any history of tamsulosin, alfuzosin, silodosin, doxazosin, terazosin, or saw palmetto, even if you stopped years ago. Your surgeon plans the case differently when IFIS is expected.
If you are preparing for cataract surgery and take a prostate or urinary medication, the next useful reads are our pages on cataract surgery recovery, cataract surgery side effects, and laser cataract surgery. When you are ready to schedule an evaluation, contact our team and bring your complete medication list to the first visit.

